ResMed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh RMD
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if RMD is a good fit for your portfolio.
News
-
ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024
-
ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis
-
Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed’s Smallest Full-Face CPAP Mask
-
ResMed’s New AirCurve™ 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions about Care, Deliver Personalized Support, and Drive Positive Therapy Outcomes for Patients with Sleep Apnea
-
MatrixCare Earns Three 2024 Best in KLAS Awards
-
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2024
-
Wall Street analysts expect the S&P 500 to rise 19% over the next 12 months. Here are their 10 favorite stocks.
-
ResMed shares can overcome obesity-drug craze, analysts say
Trading Information
- Previous Close Price
- A$27.63
- Day Range
- A$27.65–28.29
- 52-Week Range
- A$21.14–36.37
- Bid/Ask
- A$27.87 / A$27.89
- Market Cap
- A$40.99 Bil
- Volume/Avg
- 2.1 Mil / 2.0 Mil
Key Statistics
- Price/Earnings (Normalized)
- 26.97
- Price/Sales
- 6.01
- Dividend Yield (Trailing)
- 1.03%
- Dividend Yield (Forward)
- 1.58%
- Total Yield
- 1.05%
Company Profile
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 10,140
- Website
- https://www.resmed.com
Medical Instruments & Supplies Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ISRG
| Intuitive Surgical Inc | Gtynlchjx | Sbgt | $132.1 Bil | |
BDX
| Becton Dickinson & Co | Gmmbmwbx | Vflgcjb | $67.4 Bil | |
ALC
| Alcon Inc | Qsqjsnmd | Rfwpzhx | $39.1 Bil | |
CLPBY
| Coloplast A/S ADR | Rhpqttvz | Zsj | $28.8 Bil | |
WST
| West Pharmaceutical Services Inc | Tphlrvkmr | Hkqh | $27.8 Bil | |
RMD
| ResMed Inc | Sldmfzxnv | Xfyqx | $26.1 Bil | |
BAX
| Baxter International Inc | Jxbtxrrpb | Lddwj | $20.1 Bil | |
COO
| The Cooper Companies Inc | Cnypsqzly | Hntkc | $18.0 Bil | |
HOLX
| Hologic Inc | Kllpljkd | Wjmmhy | $17.6 Bil | |
TFX
| Teleflex Inc | Gdt | Ssg | $9.8 Bil |